Mostrando ítems 1-5 de 5
Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
(BioMed Central, 2008-08)
Background: Postpartum hemorrhage (PPH) remains a major killer of women worldwide. Standard uterotonic treatments used to control postpartum bleeding do not always work and are not always available. Misoprostol's potential ...
Proposal for the inclusion of misoprostol in the WHO model list of essential medicines
(World Health Organization, 2009)